Psilocybin
California Plant-Based Psychedelics Bill Heads to Governor
It also includes plant-derived DMT and mescaline.
The post California Plant-Based Psychedelics Bill Heads to Governor appeared first on Green Market R…
The California state Senate approved a bill that would decriminalize the possession and use of specific plant- and fungus-derived psychedelics, Law360 reported Thursday. The bill now awaits Gov. Gavin Newsom’s decision.
Previously, the General Assembly endorsed the bill with a 43-15 vote, following the state Senate’s initial approval in May by a 21-16 margin.
San Francisco state senator Scott Wiener sponsored SB 58. The legislation covers personal possession of substances such as psilocybin and psilocin, commonly found in certain mushrooms. It also includes plant-derived DMT and mescaline. However, the bill excludes mescaline sourced from the peyote cactus, recognizing its role in some Native American religious ceremonies.
“California’s veterans, first responders, and others struggling with PTSD, depression, and addiction deserve access to these promising plant medicines,” Wiener said in a statement. “S.B. 58 has prudent safeguards in place after we incorporated feedback from three years of deep engagement with a broad array of stakeholders.”
Amendments to the legislation removed ibogaine from the list of substances and introduced the idea of a state health agency advisory group. This group’s mandate will be to provide guidance on policies concerning these substances’ therapeutic use.
Should the bill become law, adults 21 and over would be allowed to possess up to 4 grams of the specified substances. The bill also outlines penalties for those providing psychedelics to individuals under 21.
If Newsom gives his nod to the measure, its provisions would come into effect on Jan. 1, 2025. This would mark California as the third state to decriminalize certain psychedelics, joining Oregon and Colorado, which made similar decisions in 2020 and 2022, respectively.
The post California Plant-Based Psychedelics Bill Heads to Governor appeared first on Green Market Report.
peyote mescaline ibogaine psilocybin dmt depression ptsd-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update
-
Law & Regulation1 week ago
Horizons talk shifts from investors to insurance
-
Law & Regulation1 week ago
DEA psychedelics ban hearing halted by lawsuit
-
Law & Regulation6 days ago
Relmada loses another $21.8M, makes progress with clinical trials
-
Psychedelics5 days ago
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001